The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and immune suppression by reducing oxidative stress.

[1]  M. Manns,et al.  Myeloid derived suppressor cells in human diseases. , 2011, International immunopharmacology.

[2]  K. Naka,et al.  Maintenance of genomic integrity in hematopoietic stem cells , 2011, International journal of hematology.

[3]  Lyle L. Moldawer,et al.  A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma , 2011, Molecular medicine.

[4]  Daohong Zhou,et al.  Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. , 2011, Stem cells and development.

[5]  G. Lyman,et al.  Risk of mortality in patients with cancer who experience febrile neutropenia , 2010, Cancer.

[6]  G. Schwarzer,et al.  Twist and Shout: One Decade of Meta-Analyses of Erythropoiesis-Stimulating Agents in Cancer Patients , 2010, Acta Haematologica.

[7]  D. Townsend,et al.  Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  G. Kuttan,et al.  Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice , 2010, Inflammopharmacology.

[9]  D. Townsend,et al.  Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  K. Sheng,et al.  Reactive Oxygen Species Level Defines Two Functionally Distinctive Stages of Inflammatory Dendritic Cell Development from Mouse Bone Marrow , 2010, The Journal of Immunology.

[11]  A. Burnett,et al.  Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells. , 2010, Blood.

[12]  A. Al-Khami,et al.  Cyclophosphamide Induces Dynamic Alterations in the Host Microenvironments Resulting in a Flt3 Ligand-Dependent Expansion of Dendritic Cells , 2010, The Journal of Immunology.

[13]  S. Pazhanisamy,et al.  Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. , 2009, Free radical biology & medicine.

[14]  D. Cole,et al.  Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo. , 2010, Cellular immunology.

[15]  G. Kuttan,et al.  Cardiospermum halicacabum inhibits cyclophosphamide induced immunosupression and oxidative stress in mice and also regulates iNOS and COX-2 gene expression in LPS stimulated macrophages. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[16]  E. Fibach,et al.  Effect of Iron Chelators on Labile Iron and Oxidative Status of Thalassaemic Erythroid Cells , 2009, Acta Haematologica.

[17]  M. Manns,et al.  Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor , 2009, Hepatology.

[18]  M. Manns,et al.  Increase in frequency of myeloid‐derived suppressor cells in mice with spontaneous pancreatic carcinoma , 2009, Immunology.

[19]  R. Fuchs,et al.  Acute adrenergic stress inhibits proliferation of murine hematopoietic progenitor cells via p38/MAPK signaling. , 2009, Stem cells and development.

[20]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[21]  A. Al-Khami,et al.  Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)1 , 2009, The Journal of Immunology.

[22]  D. Townsend,et al.  Pharmacology of a mimetic of glutathione disulfide, NOV-002. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  Holger Schulz,et al.  Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. , 2009, The Cochrane database of systematic reviews.

[24]  E. Garrett-Mayer,et al.  Daily injections of the glutathione disulfide mimetic NOV-002 ameliorates hematologic toxicities from neoadjuvant chemotherapy in breast cancer patients enrolled in the NEO-NOVO trial, and significantly increases circulating dendritic cells. , 2009 .

[25]  S. Ghaffari.  Oxidative stress in the regulation of normal and neoplastic hematopoiesis. , 2008, Antioxidants & redox signaling.

[26]  K. Naka,et al.  Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. , 2008, Antioxidants & redox signaling.

[27]  M. Manns,et al.  Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. , 2008, Gastroenterology.

[28]  M. Manns,et al.  A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. , 2008, Gastroenterology.

[29]  D. Townsend,et al.  NOV-002, a mimetic of glutathione disulfide , 2008, Expert opinion on investigational drugs.

[30]  D. Townsend,et al.  NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance. , 2008, Cancer research.

[31]  V. Bronte,et al.  Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.

[32]  A. C. Santos,et al.  Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver , 2008, Journal of applied toxicology : JAT.

[33]  K. Miyamoto,et al.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool , 2009 .

[34]  M. Gokhale,et al.  Cost of neutropenic complications of chemotherapy. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  M. Nishimura,et al.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy , 2008, Cancer Immunology, Immunotherapy.

[36]  Keisuke Ito,et al.  Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. , 2007, Biochemical and biophysical research communications.

[37]  S. Sharkis,et al.  A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. , 2007, Blood.

[38]  A. Cederbaum,et al.  The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin. , 2007, Free radical biology & medicine.

[39]  W. Gillanders,et al.  Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid Cells , 2007, Journal of immunotherapy.

[40]  A. Neugut,et al.  Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women , 2006, Breast Cancer Research and Treatment.

[41]  Keisuke Ito,et al.  Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.

[42]  J. Crawford,et al.  Myelotoxicity from chemotherapy. , 2006, Seminars in oncology.

[43]  Paolo Serafini,et al.  Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.

[44]  Yanmei Wang,et al.  A novel thiol oxidation‐based mechanism for adriamycin‐induced cell injury in human macrophages , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  T. Illidge,et al.  Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells. , 2005, Cancer research.

[46]  D. Townsend,et al.  Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. , 2005, Methods in enzymology.

[47]  G. Schwarzer,et al.  Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. , 2004, The Cochrane database of systematic reviews.

[48]  Daohong Zhou,et al.  Ionizing radiation and busulfan inhibit murine bone marrow cell hematopoietic function via apoptosis-dependent and -independent mechanisms. , 2003, Experimental hematology.

[49]  J. A. Campillo,et al.  Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism1 , 2001, The Journal of Immunology.

[50]  A. Zander,et al.  Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. , 1995, Bone marrow transplantation.

[51]  J. Down,et al.  Murine haemopoietic stem cells with long-term engraftment and marrow repopulating ability are more resistant to gamma-radiation than are spleen colony forming cells. , 1992, International journal of radiation biology.

[52]  Der,et al.  An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. , 1989, Blood.